Preventing flu in household contacts with sebaloxavir
Part of Infections clinical trials.
This trial tests if a single dose of sebaloxavir can prevent flu in people who live with someone who has the flu. If you live with someone who tested positive for flu and you have no flu symptoms yet, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 2 years old or older.
- You have lived with a person who has the flu (the 'index participant') for at least 2 days.
- You will continue living with that person for at least 7 days after starting the study.
- You do not currently have a fever (under 37°C / 98.6°F) or any flu symptoms.
- You have not had a flu vaccine in the past 6 months.
- You have not taken any flu medication in the past 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
This trial tests two flu medicines—Tamiflu and Xofluza—to see if they can prevent flu in people who are staying in a hospital room with a patient who has the flu. You may join if you are a hospitalized close contact (roommate or caregiver) and test negative for flu.
This trial tests a traditional Chinese herbal formula called Xuanfei Jiangzhuo Decoction to see if it helps people with COPD who get sick with the flu. It may reduce the severity of flare-ups caused by influenza.
This study tests how well a single-dose flu treatment (baloxavir marboxil) works for children with the flu and whether it stops the flu from spreading to family members. If your child has early flu symptoms and lives with others, participation could help protect your household.
This trial tests if the antiviral drug baloxavir can help adults hospitalized with influenza recover faster. It compares baloxavir to a placebo to see if it improves symptoms and outcomes.
This trial tests whether two flu medicines—baloxavir and oseltamivir—work better to treat influenza in people with weakened immune systems (like transplant or blood cancer patients). It may help reduce severe complications, especially when flu affects the lungs or is at high risk to do so.
Hear when a new Influenza Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.